Introduction
发表于 2025-4-1 05:10:04
Biomarkers in Kidney Transplantation,of biomarkers. This review is focused on recently developed biomarkers in acute rejection and tolerance as the two most important processes in decision-making about immunosuppressive therapy. The clinical utilities and limitations of these markers are discussed in details.
漫不经心
发表于 2025-4-1 07:42:58
BLyS and APRIL Cytokines as Biomarkers of Kidney Diseases,e, bone marrow, synovium, and kidney. Even though both cytokines share a common receptor on the B-cells, however, their roles in B-cell activation are significantly different. When BLyS is activated, this will result in severe B-cell hyperplasia in BLyS-transgenic mice. In contrast, when APRIL is ac
恶心
发表于 2025-4-1 11:57:38
http://reply.papertrans.cn/19/1879/187815/187815_63.png
哄骗
发表于 2025-4-1 17:55:08
Chemokines as Potential Markers in Pediatric Renal Diseases, diseases were CCL2/MCP-1 and CXCL8/IL-8. In glomerular diseases, high urinary levels of CCL2/MCP-1 have been associated to FSGS, lupus nephritis and IgA nephropathy. On the other hand, urinary levels of CXCL8/IL-8 positively correlated with proteinuria in pediatric patients with primary nephrotic s
宴会
发表于 2025-4-1 21:06:48
Chronic Allograft Damage Index (CADI) as a Biomarker in Kidney Transplantation,tocol biopsies taken after transplantation, correlates with graft function and later outcome and can be used as a surrogate marker in clinical trials. CADI has also been extensively studied in experimental models of kidney transplantation. In addition, CADI can be useful in clinical decision-making,